• Over 16 million people in America suffer from neuropathic pain. This pain stems from either nerve injury, disease states, or toxic insults. A study from the National Institutes of Health researched whether cannabinoids, like CBD, could be used to address this unmet need. The results are pretty remarkable. In this double-blind, randomized, placebo-controlled, parallel group study, it was analyzed whether cannabinoids could help peripheral neuropathic pain (PNP) treatment.  For 15 weeks, the group study was analyzed and investigated. Over 300 people with peripheral neuropathic pain. This pain was associated with...

  •   The National Institutes of Health have a study regarding multiple sclerosis. To set the scene, it begins by stating: “Inflammation in the central nervous system (CNS) is a complex process that involves a multitude of molecules and effectors, and it requires the transmigration of blood leukocytes across the blood-brain barrier (BBB) and the activation of resident immune cells. Cannabidiol (CBD), a non-psychotropic cannabinoid constituent of Cannabis sativa, has potent anti-inflammatory and immunosuppressive properties. Yet, how this compound modifies the deleterious effects of inflammation in TMEV-induced demyelinating disease (TMEV-IDD) remains...

  • According to the ALS association, “Every day, an average of 15 people are newly diagnosed with ALS — more than 5,600 people per year. As many as 30,000 Americans may currently be affected by ALS. Annually, ALS is responsible for two deaths per 100,000 people. The average life expectancy of a person with ALS is two to five years from time of diagnosis.  With recent advances in research and improved medical care, many patients are living longer, more productive lives.” One method of medical care that is gaining popularity is...

  • A recent study performed by the University of Louisville School of Medicine may have found a new therapeutic treatment for Alzheimer’s Disease and Parkinson’s Disease. Both are neurodegenerative diseases involved with GPR3 and GPR6 - members of constitutively active, G protein-coupled receptors.  “Previously, it has been reported that GPR3 is involved in Alzheimer's disease whereas GPR6 plays potential roles in Parkinson's disease. GPR3 and GPR6 are considered orphan receptors because there are no confirmed endogenous agonists for them.” However, it was then discovered that GPR3 and GPR6 are phylogenetically related...

  • If we walk into a nursing home, hospital, or other health facility, chances are pretty high that we will see at least a few people struggling with a neurodegenerative disorders. In America, it is one of the main causes of death. These disorders are often distinguished by a loss of neurons in specific regions of the nervous system. It is believed that this nerve cell loss is the primary reason for cognitive and motor function dysfunction for those with a neurodegenerative disorder. According to this study, inflammation is one of...

  • Over 60,000 Americans are diagnosed with Parkinson’s Disease (PD) each year, while approximately 10,000,000 people worldwide live with the effects of this disease. PD is caused by a loss of brain cells in the substantia nigra, the part of the brain that produces dopamine (a chemical messenger). So, it is no surprise that Cannabidiol (CBD) has been shown to help those with PD find some relief from the symptoms. This study showed that while there were no adverse effects, and no worsening of motor function, it did decrease the total...

  • That's Natural! is excited about the discoveries being made about cannabidiol (CBD) and the inherent endocannabinoid system that exists in each of our bodies.  We hope you will do research for yourself, here are some links to investigate for yourself, concerning CBD’s potential applications for Parkinson's disease. 1- Cannabidiol for the treatment of psychosis in Parkinson’s disease 2- Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties 3- Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson’s...

  • The neurodevelopment disorder, autism, affects about one in every 68 children - a staggering statistic that is bringing greater awareness to natural, plant-based therapies that are readily accessible. Parents are often left with the choice of administering antipsychotic medications to their child that are not always effective and can have negative and damaging side-effects. In Israel, a pioneering study is under way to test the effects of cannabinoids on 120 autistic children and young adults.  From Start-Up Israel:  “The researchers at Shaare Zedek are mostly administering a cannabinoid called cannabidiol,...

  • A growing body of research coupled with thousands of individuals' testimonies from around the world are bringing to light the power of CBD for health and wellness. This article from Civilized, "5 Ways CBD Can Improve Health", summarizes several of the ways that this non-psychotropic (doesn't get you "high") cannabinoid from cannabis or hemp is saving peoples' quality of life: 1. Anti-Tumor Properties 2. Anti-Anxiety Properties 3. Anti-Seizure/Anti-Convulsion Properties  4. Antioxidant Properties 5. Neuroprotective Properties Researchers, scientists, and individuals from around the world are turning towards a natural plant that has been used for...